198 related articles for article (PubMed ID: 2095562)
1. The pharmacokinetics of beta-cyclodextrin and hydroxypropyl-beta-cyclodextrin in the rat.
Frijlink HW; Visser J; Hefting NR; Oosting R; Meijer DK; Lerk CF
Pharm Res; 1990 Dec; 7(12):1248-52. PubMed ID: 2095562
[TBL] [Abstract][Full Text] [Related]
2. Parenteral hydroxypropyl cyclodextrins: intravenous and intracerebral administration of lipophiles.
Pitha J; Gerloczy A; Olivi A
J Pharm Sci; 1994 Jun; 83(6):833-7. PubMed ID: 9120816
[TBL] [Abstract][Full Text] [Related]
3. Determination of hydroxypropyl-beta-cyclodextrin in plasma and urine by size-exclusion chromatography with post-column complexation.
Szathmary SC
J Chromatogr; 1989 Jan; 487(1):99-105. PubMed ID: 2715279
[TBL] [Abstract][Full Text] [Related]
4. Absorption, distribution and excretion of beta-cyclodextrin and glucosyl-beta-cyclodextrin in rats.
Kubota Y; Fukuda M; Muroguchi M; Koizumi K
Biol Pharm Bull; 1996 Aug; 19(8):1068-72. PubMed ID: 8874818
[TBL] [Abstract][Full Text] [Related]
5. The effects of cyclodextrins on the disposition of intravenously injected drugs in the rat.
Frijlink HW; Franssen EJ; Eissens AC; Oosting R; Lerk CF; Meijer DK
Pharm Res; 1991 Mar; 8(3):380-4. PubMed ID: 2052529
[TBL] [Abstract][Full Text] [Related]
6. Comparative studies of the fate of free and liposome-entrapped hydroxypropyl-beta-cyclodextrin/drug complexes after intravenous injection into rats: implications in drug delivery.
McCormack B; Gregoriadis G
Biochim Biophys Acta; 1996 Dec; 1291(3):237-44. PubMed ID: 8980638
[TBL] [Abstract][Full Text] [Related]
7. Cyclodextrins as mucosal absorption promoters of insulin. II. Effects of beta-cyclodextrin derivatives on alpha-chymotryptic degradation and enteral absorption of insulin in rats.
Shao Z; Li Y; Chermak T; Mitra AK
Pharm Res; 1994 Aug; 11(8):1174-9. PubMed ID: 7971720
[TBL] [Abstract][Full Text] [Related]
8. Safety of oral cyclodextrins: effects of hydroxypropyl cyclodextrins, cyclodextrin sulfates and cationic cyclodextrins on steroid balance in rats.
Gerloczy A; Hoshino T; Pitha J
J Pharm Sci; 1994 Feb; 83(2):193-6. PubMed ID: 8169787
[TBL] [Abstract][Full Text] [Related]
9. Hydroxypropylcyclodextrins in parenteral use. II: Effects on transport and disposition of lipids in rabbit and humans.
Irie T; Fukunaga K; Garwood MK; Carpenter TO; Pitha J; Pitha J
J Pharm Sci; 1992 Jun; 81(6):524-8. PubMed ID: 1522488
[TBL] [Abstract][Full Text] [Related]
10. Hydroxypropyl-beta-cyclodextrin-flutamide inclusion complex. II. Oral and intravenous pharmacokinetics of flutamide in the rat.
Zuo Z; Tam YK; Diakur J; Wiebe LI
J Pharm Pharm Sci; 2002; 5(3):292-8. PubMed ID: 12553899
[TBL] [Abstract][Full Text] [Related]
11. Kinetic study of a 2-hydroxypropyl-beta-cyclodextrin-based formulation of all-trans-retinoic acid in Sprague-Dawley rats after oral or intravenous administration.
Lin HS; Chan SY; Low KS; Shoon ML; Ho PC
J Pharm Sci; 2000 Feb; 89(2):260-7. PubMed ID: 10688755
[TBL] [Abstract][Full Text] [Related]
12. Safety of parenteral hydroxypropyl beta-cyclodextrin.
Carpenter TO; Gerloczy A; Pitha J
J Pharm Sci; 1995 Feb; 84(2):222-5. PubMed ID: 7738806
[TBL] [Abstract][Full Text] [Related]
13. The effect of parenterally administered cyclodextrins on cholesterol levels in the rat.
Frijlink HW; Eissens AC; Hefting NR; Poelstra K; Lerk CF; Meijer DK
Pharm Res; 1991 Jan; 8(1):9-16. PubMed ID: 2014215
[TBL] [Abstract][Full Text] [Related]
14. Absorption, distribution and excretion of galactosyl-beta-cyclodextrin and mannosyl-beta-cyclodextrin in rats.
Kubota Y; Sanbe H; Koizumi K
Biol Pharm Bull; 2000 Apr; 23(4):472-6. PubMed ID: 10784430
[TBL] [Abstract][Full Text] [Related]
15. Pharmacokinetic analysis of 6-monoamino-beta-cyclodextrin after intravenous or oral administration to rats using a specific enzyme immunoassay.
Créminon C; Djedaïni-Pilard F; Vienet R; Péan C; Grognet JM; Grassi J; Perly B; Pradelles P
J Pharm Sci; 1999 Mar; 88(3):302-5. PubMed ID: 10052987
[TBL] [Abstract][Full Text] [Related]
16. [Pharmacokinetics Study on Curcumin Hydroxypropyl-β-Cyclodextrin Phospholipid Complex in Rats].
Luo JC; Hu XY; Wu JY; Zhao DZ; Zhang JQ
Zhong Yao Cai; 2015 Mar; 38(3):572-5. PubMed ID: 26495662
[TBL] [Abstract][Full Text] [Related]
17. Controlled systemic absorption and increased anesthetic effect of bupivacaine following epidural administration of bupivacaine-hydroxypropyl-beta-cyclodextrin complex.
Fréville JC; Dollo G; Le Corre P; Chevanne F; Le Verge R
Pharm Res; 1996 Oct; 13(10):1576-80. PubMed ID: 8899854
[TBL] [Abstract][Full Text] [Related]
18. Absorption, distribution, excretion and metabolism of orally administered 14C-beta-cyclodextrin in rat.
Gerlóczy A; Fónagy A; Keresztes P; Perlaky L; Szejtli J
Arzneimittelforschung; 1985; 35(7):1042-7. PubMed ID: 4052138
[TBL] [Abstract][Full Text] [Related]
19. New injectable aqueous carbamazepine solution through complexing with 2-hydroxypropyl-beta-cyclodextrin: tolerability and pharmacokinetics after intravenous injection in comparison to a glycofurol-based formulation.
Löscher W; Hönack D; Richter A; Schulz HU; Schürer M; Düsing R; Brewster ME
Epilepsia; 1995 Mar; 36(3):255-61. PubMed ID: 7614909
[TBL] [Abstract][Full Text] [Related]
20. Increased bioavailability of clomipramine after sublingual administration in rats.
Yoo SD; Yoon BM; Lee HS; Lee KC
J Pharm Sci; 1999 Nov; 88(11):1119-21. PubMed ID: 10564058
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
